FDA Reaches $1.25M Deal Over Mislabeled ASP Products
The U.S. Food and Drug Administration said Wednesday it has reached a $1.25 million settlement with Advanced Sterilization Products and two of its executives over allegations that the company knowingly distributed...To view the full article, register now.
Already a subscriber? Click here to view full article